Hearn Jay Cho, MD, PhD
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:Hematology-Oncology, Cancer (Oncology)
Multi-Disciplinary Training AreasBiophysics and Systems Pharmacology [BSP], Cancer Biology [CAB], Developmental and Stem Cell Biology [DSCB], Immunology [IMM]
MD, Cornell University Medical College
Residency, Internal Medicine, University of California, San Diego
Fellowship, Postdoctoral Researc, University of California, San Diego
Fellowship, Hematology/Oncology, New York Presbyterian - Weill Cornell Medical Center
Fellowship, Immunology, Rockefeller University
- Phase 1 study of Elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance for multiple myeloma
The purpose of this study is to explore the combination of Elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance to see what side effects it may have and how well it works for the treatment of symptomatic multiple myeloma diagnosed an...
- A Phase Ib Study of the Saftey and Pharmacokinetics of MPDL3280A (Anti-PD-L1 Antibody) Alone or in Combination with Lenalidomide in Patients with Multiple Myeloma (Relapsed and Post-Autologous Stem Cell Transplantation)
The purpose of this study is to test the safety of the combination of an experimental drug called MPDL3280A and lenalidomide (approved by the FDA) at different dose levels, and to find out what effects, good or bad, the combination of these drugs has on you. An experimen...